FDA Approves New Formulation of Coagulation Therapy
May 9th, 2008 | By admin | Category: Health NewsThe U.S. Food and Drug Administration today approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood. The new formulation allows the product to be stored at room temperature (up to 81 degrees Fahrenheit) for up to two years.
If you’re new here, you may [...]
